
At the Precision Ocular Biobank, a division of Advancing Sight Network, we are proud to be a global leader in providing the highest-quality human ocular cells, tissues, and histology slides for research. As one of the world’s only certified ocular biobanks, we were founded to address the critical shortage of research-quality human eye tissue—and we’ve grown into a trusted partner for more than 40 leading pharmaceutical companies, biotech firms, and academic institutions around the world. The Precision Ocular Biobank has become Advancing Sight Network’s research and innovation hub.
We specialize in the careful procurement, processing, and distribution of high-quality human ocular tissues for research. Our network spans four states—providing access to a diverse range of donors, including those with rare eye conditions that are critical to advancing scientific understanding. Every step we take is grounded in rigorous ethical standards and regulatory compliance, ensuring researchers receive tissue they can trust. Just as importantly, our team collaborates closely with each research partner to understand and meet their specific needs, offering personalized support and timely, reliable delivery of ethically sourced tissue—because we know that in the pursuit of discovery, every detail matters.
Designed for both precision and speed, the Precision Ocular Biobank is one of the few eye bank systems in the world capable of recovering ocular tissue in under six hours post-mortem. This rapid response helps preserve the molecular, structural, and functional integrity of each sample we provide—enabling researchers to push the boundaries of what’s possible in vision science.
Our state-of-the-art equipment is used to image, process, and preserve the eye tissue—providing researchers with the highest quality samples essential for their exacting studies. Our ultimate goal is to help accelerate the development of new and better treatments and eventual cures for blinding eye diseases like age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma.
Our reach is global, with samples shipped to more than 30 countries. We offer both comprehensive and custom tissue solutions tailored to the unique goals of each partner.
Dr. Gregory H. Grossman, PhD is the Chief Scientific Officer and Scientific Innovation Executive Lead at Advancing Sight Network, where he provides administrative leadership and scientific oversight for all research programs and innovative initiatives focused on accelerating therapies for vision loss worldwide. Dr. Grossman heads the Precision Ocular Biobank at Advancing Sight Network, one of the few certified ocular biobanks in the world.
Read Full BioDr. Gregory H. Grossman, PhD is the Chief Scientific Officer and Scientific Innovation Executive Lead at Advancing Sight Network, where he provides administrative leadership and scientific oversight for all research programs and innovative initiatives focused on accelerating therapies for vision loss worldwide. Dr. Grossman heads the Precision Ocular Biobank at Advancing Sight Network, one of the few certified ocular biobanks in the world.
Dr. Grossman completed his fellowship in ophthalmology at the Cole Eye Institute of the Cleveland Clinic. Before joining ASN, he conducted research at the Cleveland Clinic and led clinical operations at the Cleveland Eye Bank.
He holds multiple professional certifications, including Certified Eye Bank Technician (CEBT), Certified Clinical Research Professional (CCRP), Board Certified Medical Affairs Specialist (BCMAS), and Green Lab certification through My Green Lab. Passionate about restoring sight through the healing power of eye donation, Dr. Grossman serves in leadership roles across several national and international organizations, including ARVO, EBAA, and ISBER. He is currently the President of the Board of ISBER, the global society for biobanking.
If you are a researcher needing human eye samples (cells and tissues), wishing to partner on projects/grants, or requiring critical resources to support your research goals, please visit our Precision Ocular Biobank platform.
Visit Precision Ocular Biobank